Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Income from Non-Controlling Interests: 2015-2024

Historic Income from Non-Controlling Interests for Fortress Biotech (FBIO) over the last 10 years, with Dec 2024 value amounting to $74.9 million.

  • Fortress Biotech's Income from Non-Controlling Interests rose 78.47% to -$3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.7 million, marking a year-over-year decrease of 122.03%. This contributed to the annual value of $74.9 million for FY2024, which is 19.95% down from last year.
  • According to the latest figures from FY2024, Fortress Biotech's Income from Non-Controlling Interests is $74.9 million, which was down 19.95% from $93.5 million recorded in FY2023.
  • In the past 5 years, Fortress Biotech's Income from Non-Controlling Interests ranged from a high of $93.5 million in FY2023 and a low of -$127.3 million during FY2022.
  • Moreover, its 3-year median value for Income from Non-Controlling Interests was $74.9 million (2024), whereas its average is $13.7 million.
  • Its Income from Non-Controlling Interests has fluctuated over the past 5 years, first spiked by 191.51% in 2020, then tumbled by 277.34% in 2021.
  • Yearly analysis of 5 years shows Fortress Biotech's Income from Non-Controlling Interests stood at $56.5 million in 2020, then tumbled by 277.34% to -$100.1 million in 2021, then fell by 27.18% to -$127.3 million in 2022, then surged by 173.44% to $93.5 million in 2023, then declined by 19.95% to $74.9 million in 2024.